These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32946005)

  • 21. Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.
    Blancas-Mejía LM; Tischer A; Thompson JR; Tai J; Wang L; Auton M; Ramirez-Alvarado M
    J Mol Biol; 2014 Jan; 426(2):347-61. PubMed ID: 24157440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains.
    Raffen R; Dieckman LJ; Szpunar M; Wunschl C; Pokkuluri PR; Dave P; Wilkins Stevens P; Cai X; Schiffer M; Stevens FJ
    Protein Sci; 1999 Mar; 8(3):509-17. PubMed ID: 10091653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate.
    Abe Y; Odawara N; Aeimhirunkailas N; Shibata H; Fujisaki N; Tachibana H; Ueda T
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2570-2578. PubMed ID: 30251653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic evidence for multiple aggregation pathways in antibody light chain variable domains.
    Wong S; West ME; Morgan GJ
    Protein Sci; 2024 Mar; 33(3):e4871. PubMed ID: 38100259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
    Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
    J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoglobulin light chain amyloid aggregation.
    Blancas-Mejia LM; Misra P; Dick CJ; Cooper SA; Redhage KR; Bergman MR; Jordan TL; Maar K; Ramirez-Alvarado M
    Chem Commun (Camb); 2018 Sep; 54(76):10664-10674. PubMed ID: 30087961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein.
    Tveteraas T; Sletten K; Westermark P
    Biochem J; 1985 Nov; 232(1):183-90. PubMed ID: 3936482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cryo-EM STRUCTURE of Renal Amyloid Fibril Suggests Structurally Homogeneous Multiorgan Aggregation in AL Amyloidosis.
    Puri S; Schulte T; Chaves-Sanjuan A; Mazzini G; Caminito S; Pappone C; Anastasia L; Milani P; Merlini G; Bolognesi M; Nuvolone M; Palladini G; Ricagno S
    J Mol Biol; 2023 Sep; 435(18):168215. PubMed ID: 37516426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
    Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
    PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The amino acid sequence of a glycosylated AL-chain from a patient with primary amyloidosis.
    Myran T; Husby G; Kyle RA; Sletten K
    Amyloid; 2004 Jun; 11(2):109-12. PubMed ID: 15478466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains.
    Kim YS; Cape SP; Chi E; Raffen R; Wilkins-Stevens P; Stevens FJ; Manning MC; Randolph TW; Solomon A; Carpenter JF
    J Biol Chem; 2001 Jan; 276(2):1626-33. PubMed ID: 11050093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
    Tycko R; Wickner RB
    Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural alterations within native amyloidogenic immunoglobulin light chains.
    Randles EG; Thompson JR; Martin DJ; Ramirez-Alvarado M
    J Mol Biol; 2009 May; 389(1):199-210. PubMed ID: 19361523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
    Weber B; Hora M; Kazman P; Göbl C; Camilloni C; Reif B; Buchner J
    J Mol Biol; 2018 Dec; 430(24):4925-4940. PubMed ID: 30414962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis.
    Rottenaicher GJ; Absmeier RM; Meier L; Zacharias M; Buchner J
    Commun Biol; 2023 Feb; 6(1):209. PubMed ID: 36823438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding.
    Blancas-Mejía LM; Horn TJ; Marin-Argany M; Auton M; Tischer A; Ramirez-Alvarado M
    Biophys Chem; 2015 Dec; 207():13-20. PubMed ID: 26263488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.